Vaccination

The HPV vaccine protects against diseases caused by the human papillomavirus (HPV). HPV, or human papillomavirus, is a very common virus that can cause malignant tumours in the genital area (including cervical cancer) as well as cancers of the head and neck area in both men and women. It can also cause genital warts. Vaccination against HPV can prevent up to 90% of precancerous conditions. The most effective protection is achieved when vaccination is given before exposure to the virus, ideally between the ages of 12 and 14.

• Young people aged 12–18 are eligible to receive the vaccine free of charge, funded by the Health Insurance Fund (parental consent is required for those aged 12–17 years). At this age, one vaccine dose is sufficient.
• From the age of 19, HPV vaccination is available at the individual’s own expense. The vaccination schedule consists of 2–3 doses administered over a period of 12 months, and these costs are not covered by the Health Insurance Fund.